Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders
Status:
Recruiting
Trial end date:
2028-09-20
Target enrollment:
Participant gender:
Summary
Compare key clinical outcomes between controls and men treated with a novel CCH
administration protocol among men previously unresponsive to CCH administration.
Phase:
Phase 4
Details
Lead Sponsor:
Charitable Union for the Research and Education of Peyronie's Disease